Harris Kyriakides
Harris Kyriakides

Expertise

Where legal acumen meets innovative solutions

Healthcare & Life Sciences

The healthcare and life sciences sectors are experiencing transformative changes, presenting both opportunities and challenges for businesses operating within these fields. Companies are navigating a complex landscape marked by rising costs, regulatory scrutiny, and the need for innovation. As expiring patents and competitive pressures emerge, life sciences organisations are adapting their strategies to maintain market relevance and drive growth. Collaborations across borders and sectors are fostering innovative approaches to the commercialisation of intellectual property and ground-breaking transactions.

At Harris Kyriakides, we leverage our deep industry knowledge to deliver tailored solutions that enhance value and anticipate market shifts. We work closely with clients to provide strategic advice on critical transactions, dispute resolution, merger control, regulatory compliance, contracts, and licensing agreements. Recognising the central role of innovation, we support leading healthcare and life sciences companies in maximising their intellectual property assets and navigating complex market transactions.

In the dynamic landscape of Healthcare and Life Sciences, Harris Kyriakides offers reliable legal counsel to help clients navigate the intricacies of these sectors. Our extensive expertise encompasses a wide range of legal services tailored to meet the needs of both local and international clients. Collaborating across various practice areas, we provide expert guidance on corporate finance, intellectual property, tax, and trade issues.

Healthcare
We provide comprehensive legal support across diverse healthcare entities, including hospitals, health systems, academic medical centers, and retail pharmacies. Our services address the multifaceted needs of our healthcare clients, offering advice on transactions, telemedicine, insurance coverage and reimbursement, medical liability claims, healthcare fraud, and abuse issues, clinical integration, and the construction and licensing of healthcare facilities.

Life Sciences
Our focus on the life sciences sector encompasses pharmaceuticals, biotechnology, and medical devices. We specialise in protecting and commercialising innovative products, navigating complex patent litigation, and fostering innovation through robust intellectual property strategies. With a global perspective, we offer clients strategies to maintain a competitive edge in the international life sciences market, guiding them through mergers and acquisitions to ensure seamless transitions.

Our legal team represents a wide array of clients in the healthcare and life sciences sectors, including hospitals, health systems, long-term care facilities, retail pharmacies, wholesale distributors, multidisciplinary physician groups, and health insurers. Our lawyers maintain strong relationships with an international network of legal professionals, enabling us to provide a cross-border approach to litigation, transactional, and regulatory matters, ensuring that our clients receive comprehensive and informed legal guidance tailored to their specific needs.

RELEVANT EXPERTS

LATEST NEWS

News
EU seeks to ban “forever chemicals” in consumer products
12 November 2024 | 4 mins read

The European Commission’s new initiative to phase out “forever chemicals” from consumer products marks a significant shift in the European market, impacting industries across various sectors.  Background “Forever chemicals”, formally known as per- and polyfluoroalkyl - Read More...

Publications & Commentaries
Pharmaceutical Advertising 2024
26 March 2024 | 1 min read

We are delighted to share the latest International Comparative Legal Guide – Pharmaceutical Advertising 2024, published by Chambers & Partners.

By Eleni Neoptolemou, Munevver Kasif

Publications & Commentaries
Comparative Legal Guide – Pharmaceutical Advertising and Regulations 2023
21 July 2023 | 1 min read

We are delighted to share the latest International Comparative Legal Guide – Pharmaceutical Advertising and Regulations 2023, published by Global Legal Group.

By Michael Kyriakides, Eleni Neoptolemou, Munevver Kasif

Publications & Commentaries
International Comparative Legal Guide: Drug & Medical Device Litigation 2023
20 April 2023 | 1 min read

Harris Kyriakides team contributes the Cyprus chapter in the International Comparative Legal Guide: Drug & Medical Device Litigation 2023 by Global Legal Group.

By Eleni Neoptolemou, Munevver Kasif

News
Medical negligence case study GA v Dr AP
23 November 2022 | 3 mins read

The court’s verdict was that there was medical negligence, due to which the plaintiff suffered an everlasting serious bodily injury but did not award damages for future wage loss.

News
Infectious or Contagious Disease Clause for Time Charter Parties 2022
24 August 2022 | 4 mins read

BIMCO issued the new Infectious or Contagious Disease Clause for Time Charter Parties 2022 replacing the 2015 Disease Clause to provide a revised standard clause for Time Charter Parties in cases of future pandemics and - Read More...

Publications & Commentaries
Global Legal Group – Pharmaceutical Advertising 2022
20 July 2022 | 1 min read

Harris Kyriakides team contributes the Cyprus chapter in Pharmaceutical Advertising 2022 by Global Legal Group.

By Eleni Neoptolemou, Munevver Kasif, Maria Constanti

Publications & Commentaries
International Comparative Legal Guide – Drug & Medical Device Litigation 2022
27 April 2022 | 1 min read

Harris Kyriakides team contributes the Cyprus chapter in the International Comparative Legal Guide: Drug & Medical Device Litigation 2022. 

By Eleni Neoptolemou, Munevver Kasif